Emerald Health Therapeutics Closes Shares for Debt Transaction

Emerald Health Therapeutics and STENOCARE Receive Swedish Medicines Agency Approval to Provide Medical Cannabis Oil to Patients

Emerald Health Therapeutics Enters into Share Purchase Agreement for Sale of Pure Sunfarms

Emerald Health Therapeutics Reports Second Quarter 2020 Financial Results and Provides Corporate Update

Emerald Health Therapeutics Launches New Fast-Acting Cannabis Spray Products Offering Consumers Significantly Improved Predictability and Control of Effects

Emerald Health Therapeutics’ Pure Sunfarms Joint Venture Begins Shipping Cannabis 2.0 Products and Bottled Oils

Emerald Health Therapeutics Announces Shares for Debt Transaction

Emerald Health Therapeutics Reports Pure Sunfarms Second Quarter 2020 Financial Results

Emerald Health Therapeutics Announces New At-The-Market Equity Program

Emerald Health Therapeutics Announces Stock Option Grant